Start Your NewsReadery Pro FREE TRIAL!

Register and verify your email address to start your NewsReadery Pro FREE TRIAL today!

Login / Register

#durhamnorthcarolina

Quick Menu features require JavaScript!
Popular News
 
VIVJOA provided nearly 2 years of sustained efficacy against RVVC in a long-term extension of Phase 3 studies DURHAM, N.C., Nov. 18, 2025 /PRNewswire/ -- Mycovia Pharmaceuticals, Inc. ("Mycovia") has announced the publication of long-term efficacy ...
Continue
Please wait ...